Notice ID: c95df431e8484abd93db52a5ebc0ae31Combined Synopsis/Solicitation
Integra Automation Bundle
Archived on September 11, 2024. Original response deadline: . Full description on SAM.gov.
Overview
- Response deadline
- 1:00 PM UTC−04:00
- Posted
- August 21, 2024
- Notice type
- Combined Synopsis/Solicitation
- NAICS
- 334516: Analytical Laboratory Instrument Manufacturing
- Agency
- Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH
Notice details
- Office
- NATIONAL INSTITUTES OF HEALTH NIDA
- Last updated
- Sep 25, 2026
Identifiers
- Solicitation number
- 75N95024Q00436
- Notice ID
- c95df431e8484abd93db52a5ebc0ae31
Description
Solicitation No. 75N95024Q00436 Title: Single Cell RNAseq Protocol and Automation Bundle 1. This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in Subpart 12.6 as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested and a separate written solicitation will not be issued. 2. The solicitation number is 75N95024Q00436 and the solicitation is issued as a Request for Quotation (RFQ) on an unrestricted basis, as a full and open requirement. This acquisition is for a commercial item or service and is conducted under the authority of the Federal Acquisition Regulation (FAR) Part 13—Simplified Acquisition Procedures; FAR Subpart 13.5— Simplified Procedures for Certain Commercial Items; and FAR Part 12—Acquisition of Commercial Items, and is not expected to exceed the simplified acquisition threshold. A time and materials type of purchase order is contemplated for this requirement. 3. The solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular 2024-06, dated 07-30-2024. 4. The North American Industry Classification System (NAICS) code for this procurement is 334516 - Analytical Laboratory Instrument Manufacturing with associated small business size standard of 1,000 employees or less. 5. Line Items: Through this procurement NIDA anticipates a single award, firm fixed price purchase order for brand name or equal scRNAseq Protocol and Automation Bundle and component parts as described in Attachment 1 – Purchase Description. Below is a table that contains the line item number and description of the brand name or equal requirements for the anticipated award. Line No. Description 1 Qty: 1. Evercode Automation Mega Package with Integra Assist Plus (SKU: NTWT3500) 2 Qty: 1. 8-channel VOYAGER Electronic Pipette 0.5 – 12.5uL (SKU: 4721) 3 Qty: 1. 8-channel VOYAGER Electronic Pipette 2 - 50uL (SKU: 4726) 4 Qty: 1. 16-channel VIAFLO Electronic Pipette 0.5 – 12.5uL (SKU: 4641) 5 Qty: 1. 16-channel VIAFLO Electronic Pipette 2 – 50uL (SKU: 4646) 6 Qty: 2. 4-pipette Charging Stand (SKU: 4215) 6. Description of Requirement: The objective of this solicitation is to purchase a brand name or equal scRNAseq Protocol and Automation Bundle for the Translational Neuroscience Center (TNC), National Institute of Stroke, NINDS. The TNC’s responsibility is to aid other labs, primarily at NINDS but also throughout the NIH, in translating their basic science discoveries into potential therapeutics. One technology the TNC is using to better understand therapeutic targets in single-cell (sc)-RNAseq. NINDS requires a scRNAseq protocol that will be used at a larger scale and in order to improve precision, accuracy, and efficiency it needs to be automated. NINDS also requires a workflow that completely automates their scRNAseq protocol. The protocol can be used to process up to a million cells and sixteen samples in one run. The purchase of this equipment will allow the TNC to scale up its capacity to run many samples for scRNAseq analysis in a timely and efficient manner and provide collaborators with critical information that can be used to better translate their findings into the clinic. 7. The provision at FAR Clause 52.212-1 Instructions to Offerors—Commercial Items (Sep 2023) is applicable to this solicitation. 8. The provision at FAR clause 52.212-2, Evaluation – Commercial Items, applies to this acquisition. The following is provided as an addendum to clause 52.212-2: The Government will award a contract resulting from this solicitation to the responsible Offeror whose offer conforming to the solicitation will be most advantageous to the Government, i.e. this RFQ will be evaluated and award made on the basis of best value to the Government. Offeror’s submitting a response must provide a completed Price Quote to be evaluated and considered for award. Price quotes must indicate fixed unit pricing and total cost, including shipping cost and estimated time of delivery after receipt of order. Technical evaluation shall be based on the following: Technical Approach NIDA shall evaluate: A tradeoff process shall be used for this acquisition because it has been determined to be in the best interest of the Government to consider award to other than the lowest priced Offeror or other than the highest technically rated offeror. All evaluation factors and significant sub-factors that will affect contract award and their relative importance will be clearly stated in the solicitation; and the solicitation shall state whether all evaluation factors other than cost or price, when combined, are significantly more important than, approximately equal to, or significantly less important than cost or price. For this acquisition, the following considerations will be part of the trade-off process: Technical Evaluation Factors including Past Performance, and Price. The evaluation will be based on the demonstrated capabilities of the prospective Offerors in relation to the needs of the project as set forth in the solicitation. The merits of each proposal will be evaluated carefully. Each proposal must document the feasibility of successful implementation of the requirements of the solicitation. Offerors must submit information sufficient to evaluate their proposals based on the detailed factors listed below. ARTICLE 1 - Evaluation Criteria A tradeoff process shall be used for this acquisition because it has been determined to be in the best interest of the Government to consider award to other than the lowest priced Offeror or other than the highest technically rated offeror. All evaluation factors and significant sub-factors that will affect contract award and their relative importance will be clearly stated in the solicitation; and the solicitation shall state whether all evaluation factors other than cost or price, when combined, are significantly more important than, approximately equal to, or significantly less important than cost or price. For this acquisition, the following considerations will be part of the trade-off process: Technical Evaluation Factors including Past Performance, and Price. TECHNICAL EVALUATION FACTORS The evaluation factors are used by the technical evaluation committee when reviewing the technical quotes. The factors below are listed with weights assigned indicating relative importance for evaluation purposes, i.e., a higher weight indicates higher importance. 1. Technical Capability and Functionality NIDA shall evaluate the offeror’s technical approach for overall capability and functionality in relation to the General Requirement, Salient Characteristics, Quantity and Deliverables as described in the Statement of Work. 2. Contract Management and Customer Support NIDA shall evaluate the offeror’s ability to provide a high level of customer service, particularly in the area of initial responsiveness and resolution of device and service problems. Specifically, the Government will evaluate the Offeror’s capability based on its description of any applicable warranty, customer support process. 3. Speed of Delivery, Installation and Set-up NIDA shall evaluate the offeror’s technical approach for completeness, feasibility, soundness and practicality of the proposed approach and work plan for accomplishing the requirements of the Statement of Work. PAST PERFORMANCE Offerors will be evaluated based on information obtained from references provided by the offeror, other relevant past performance information obtained from other sources known to the Government, and any information supplied by the offeror concerning problems encountered on the identified contracts and corrective action taken. Furthermore, the Government will assess the relative risks associated with each offeror. Performance risks are those associated with an offeror's likelihood of success in performing the acquisition requirements as indicated by that offeror's record of past performance. The assessment of performance risk is not intended to be the product of a mechanical or mathematical analysis of an offeror's performance on a list of contracts but rather the product of subjective judgment by the Government after it considers all available and relevant information. PRICE EVALUATION Offerors price quote will be evaluated for reasonableness. For a price to be reasonable, it must represent a price to the government that a prudent person would pay when consideration is given to prices in the market. Normally, price reasonableness is established through adequate price competition, but may also be determined through cost and price analysis techniques. Price evaluation will not be conducted on any Offeror determined to be technically unacceptable. The award will be made on a competitive best value basis, using “tradeoff” among cost/price and non-cost/price factors. The Government may elect to award to other than the lowest priced Offeror, or other than the Offeror with the highest rated non-cost/price proposal. In either case, a tradeoff will be conducted. The government reserves such right of flexibility in conducting the evaluation as necessary to assure an award with the Contractor providing the best value to the government. The major evaluation factors for this solicitation include technical and cost/price factors. Interrelationships of these elements will be assessed consistent with the regulations concerning the considerations of cost and other factors in determining contract award. Technical factors are of paramount consideration in the award of the contract, however cost/price is also important to the overall contract award decision. Therefore, Offerors are reminded that award will be made to the Offeror whose proposal provides the combination of features that offers the best or greatest overall value to the Government. The Government may request clarifying information from the schedule contractor, as it relates to its quote. (b) A written notice of award or acceptance of an offer mailed or otherwise furnished to the successful Offeror within the time for acceptance specified in the offer, shall result in a binding contract without further action by either party. Before the offer’s specified expiration time, the Government may accept an offer (or part of an offer), whether or not there are negotiations after its receipt, unless a written notice of withdrawal is received before award. 9. The Offeror is to include a completed copy of the provision at FAR clause 52.212-3, Offeror Representations and Certifications—Commercial Items, with its offer. Offerors must include the representation at 52.204-24 if it is not in in their completed FAR Representations and Certifications. A copy of that representation is attached as Attachment 2 - Representation Regarding Certain Telecommunications and Video Surveillance Services or Equipment. 10. The provision at FAR Clause 52.212-4, Contract Terms and Conditions—Commercial Items, applies to this acquisition and is supplemented by Attachment 4 - 52.212-4 Addendum and Supplemental Clauses. 11. The provision of FAR Clause 52.212-5, Contract Terms and Conditions Required to Implement Statutes or Executive Orders Commercial Items, applies to this acquisition. See attachment. 12. The following additional contract requirement(s) or terms and conditions as determined by the Contracting Officer are necessary for this acquisition and consistent with customary commercial practices. Additional contract requirement(s) or terms and conditions determined by the Contracting Officer to be necessary for this acquisition are supplemented by the following attachments: Attachment 1 – Purchase Description Attachment 2 - 52.212-4 Contract Terms and Conditions – Commercial Items (Nov 2023) Attachment 3 - 52.212-5 Contract Terms and Conditions Required to Implement Statutes or Executive Orders-Commercial Items. Attachment 4 - Invoicing Instructions 13. The Defense Priorities and Allocations System (DPAS) are not applicable to this requirement. 14. The response to the combined synopsis/solicitation is due no later than August 27, 2024 at 1:00 p.m. Eastern Standard Time (EST). Offers submitted after the deadline may not be considered. The response should be submitted in a searchable format to the Contract Specialist, Shaun Rostad at shaun.rostad@nih.gov. Electronic submittals must include the combined synopsis/solicitation 75N95024Q00436 and the Title in the Subject Line. In addition, the Unique Entity Identifier (UEI), the Taxpayer Identification Number (TIN), and the certification of business size must be included in the response. All offerors must have an active registration in the System for Award Management (SAM) www.sam.gov. Technical Quotes shall be submitted in accordance with the General Requirement identified in Section 6 of this combined synopsis/solicitation. Any Quote, modification, or revision that is received at the designated Government office after the exact date and time specified for receipt of quotations is “late” and may not be considered. Quotes received “late” may not be evaluated or considered for award and may be returned to the Offeror. If an emergency or unanticipated event interrupts normal Government processes so that Quotes cannot be received at the Government office designated for receipt of Quotes by the exact time specified in the solicitation, and urgent Government requirements preclude amendment of the solicitation closing date, the time specified for receipt of Quotes will be deemed to be extended to the same time of day specified in the solicitation on the first work day on which normal Government processes resume. The Government reserves the right to award without discussions if the Contracting Officer determines that the initial cost/prices are fair and reasonable and that discussions are not necessary. 15. Questions may be submitted to Shaun Rostad and Josh Lazarus at shaun.rostad@nih.gov and josh.lazarus@nih.gov up to August 23, 2024 at 1:00 p.m. Eastern Standard Time.
Award Overview
No prior contract identified
No prior award matched this notice's agency, NAICS, place of performance and PSC within 18 months. It may be a new requirement.
Contacts
Contracting Officer
Primary Contact
Secondary Contact
Documents
No documents available.
Lifecycle
Solicitation:
75N95024Q00436- Combined Synopsis
- Combined SynopsisCurrentAug 21, 2024
Integra Automation Bundle
Similar Opportunities
Title | Match | Phase | Deadline |
|---|---|---|---|
(i)This is a combined synopsis/solicitation for commercial items prepared in accordancewith FAR Subpart 12.6, as supplemented with additional information included in thisnotice. This announcement constitutes the only solicitation; proposals are beingrequested, and a separate written solicitation will not be issued. (ii)The solicitation number is 75N98027Q00077. This solicitation is issued as a competitiveRequest for Quotation (RFQ) / combined synopsis/solicitation for commercial productsand commercial services using a Brand Name restriction in accordance with FAR 13.106-1(b)(1)(i). A Brand Name Justification is attached to this notice in accordance with FAR5.102(a)(6). This acquisition is conducted under the authority of FAR 12.603, StreamlinedSolicitation for Commercial Products or Commercial Services, in conjunction with FAR Part13 Simplified Acquisition Procedures, and is not expected to exceed the simplifiedacquisition threshold. The National Institutes of Health (NIH), Office of the Director, Officeof Acquisitions, seeks to award a Firm-Fixed-Price (FFP) Purchase Order to theresponsible offeror whose quotation represents the best value to the Government. (iii)The solicitation document and incorporated provisions and clauses are those in effectthrough Federal Acquisition Circular (FAC) number 2026-01 and effective date 03/13/2026. (iv)The associated NAICS code is 334516 (Analytical Laboratory InstrumentManufacturing), and the small business size standard is 1,000 employees. The ProductService Code (PSC) is 6640 (Laboratory Equipment and Supplies). [X]This requirement is set aside for Small Business concerns. | - | Combined Synopsis | 11/24/2026 |
(i) This is a combined synopsis/solicitation for commercial items prepared in accordance with FAR Subpart 12.6, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested, and a separate written solicitation will not be issued. (ii) The solicitation number is 75N98027Q00072. This solicitation is issued as a competitive combined synopsis/solicitation for commercial products or commercial services restricted to the Brand Name specified herein in accordance with FAR 13.106-1(b)(1)(i). The Government intends to award a firm-fixed-price purchase order resulting from this solicitation using competition among the Original Equipment Manufacturer (OEM) and its authorized distributors. This acquisition is conducted under the authority of FAR 12.603, Streamlined Solicitation for Commercial Products or Commercial Services, and is not expected to exceed the simplified acquisition threshold. The National Institutes of Health (NIH), Office of the Director, Office of Acquisitions, on behalf of the National Heart, Lung, and Blood Institute (NHLBI), seeks to award a firm-fixed-price purchase order to the responsible offeror whose proposal represents the best value to the Government. (iii) The solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular 2026-01, effective 03/13/2026. (iv) The associated NAICS code is 334516 (Analytical Laboratory Instrument Manufacturing), and the small business size standard is 1,000 employees. ¿ This requirement is unrestricted. (v) Description of Requirement: The National Heart, Lung, and Blood Institute (NHLBI), Laboratory of Advanced Microscopy and Biophotonics (LAMB), requires one (1) Brand Name Spectra-Physics (Newport Corporation / MKS Instruments) InSight® X3¿ Dual Ultrafast Laser System to integrate with an existing Thorlabs Veneto inverted multiphoton microscope for Fluorescence Lifetime Imaging Microscopy (FLIM) and Stimulated Raman Scattering (SRS) pump-probe experiments studying the effects of chemotherapeutic agents on cellular metabolism. | - | Combined Synopsis | 11/20/2026 |
(i) This is a combined synopsis/solicitation for commercial items prepared in accordance with FAR Subpart 12.6, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested, and a separate written solicitation will not be issued. (ii) The solicitation number is 75N98027Q00064 PCA-NIA-11888. This solicitation is issued as a competitive combined synopsis/solicitation for commercial products or commercial services. The Government intends to award a contract or purchase order resulting from this solicitation using full and open competition. This acquisition is conducted under the authority of FAR 12.603, Streamlined Solicitation for Commercial Products or Commercial Services, and is not expected to exceed the simplified acquisition threshold. The National Institutes of Health (NIH), Office of the Director, Office of Acquisitions, seeks to award a firm fixed-price award to the responsible offeror whose proposal represents the best value to the Government. | - | Combined Synopsis | 12/14/2026 |
(i)This is a combined synopsis/solicitation for commercial items prepared in accordancewith FAR Subpart 12.6, as supplemented with additional information included in thisnotice. This announcement constitutes the only solicitation; proposals are beingrequested, and a separate written solicitation will not be issued. (ii)The solicitation number is 75N98027Q00061. This solicitation is issued as a competitivecombined synopsis/solicitation for commercial products or commercial services (BrandName or Equal in accordance with FAR 52.211-6). The Government intends to award acontract or purchase order resulting from this solicitation using full and open competition.This acquisition is conducted under the authority of FAR 12.603, Streamlined Solicitationfor Commercial Products or Commercial Services (and FAR Subpart 13.5, as applicable).The National Institutes of Health (NIH), Office of the Director, Office of Acquisitions, seeksto award a Firm-Fixed-Price (FFP) Purchase Order/Contract in U.S. Dollars (USD) to theresponsible offeror whose proposal represents the best value to the Government. (iii)The solicitation document and incorporated provisions and clauses are those in effectthrough Federal Acquisition Circular 2026-01 and effective date 03/13/2026. (iv)The associated NAICS code is 334516 (Analytical Laboratory InstrumentManufacturing), and the small business size standard is 1,000 employees. ¿This requirement is unrestricted. | - | Combined Synopsis | 11/18/2026 |
(i) This is a combined synopsis/solicitation for commercial items prepared in accordance with FAR Subpart 12.6, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested, and a separate written solicitation will not be issued. (ii) The solicitation number is 75N98027Q00048/PCA-NIA-12240. This solicitation is issued as a competitive combined synopsis/solicitation for commercial products or commercial services. The Government intends to award a contract or purchase order resulting from this solicitation using full and open competition. This acquisition is conducted under the authority of FAR 12.603, Streamlined Solicitation for Commercial Products or Commercial Services, and is not expected to exceed the simplified acquisition threshold. The National Institutes of Health (NIH), Office of the Director, Office of Acquisitions, seeks to award a firm fixed-price award to the responsible offeror whose proposal represents the best value to the Government. | - | Solicitation | 12/14/2026 |
Additional Details
Solicitation Number
75N95024Q00436
Archive Date
Sep 11, 2024
Office Address
Bethesda, MD, 20892